[Asia Economy Reporter Kwon Jaehee] ST Pharm announced on the 28th that its sales in the first quarter of 2022 reached 36.979 billion KRW, and operating profit was 537 million KRW. Sales increased by 35.7% compared to the same period last year, and operating profit turned positive.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing